Award-winning Austrian supplement containing “spermidine” is now available to consumers in the US

DENVER, Sept. 9, 2020 /PRNewswire/ — TLL The Longevity Labs GmbH, an Austrian-based life sciences company, and its wholly-owned, US subsidiary, Longevity Labs Inc., announce the market-launch of sales in the US of its award-winning dietary supplement, spermidineLIFE®. spermidineLIFE® is the world’s first naturally extracted and clinically tested dietary supplement to promote cellular renewal. The active ingredient, spermidine, is considered key to slowing down the cellular aging process.

Read more

Shaping the Future of Food

The Donald Danforth Plant Science Center announced the lineup of TableTalks, a series of conversations shaping the future of food that will follow each AgTech NEXT conference session on Tuesdays, September 22 – November 10 from 1:30 – 2:15 PM.

Read more

Kimera® Labs Files First FDA Investigational New Drug (IND) Application Using XoGlo® for Treatment of ARDS Secondary to COVID-19

Kimera® Labs Inc, a privately held clinical stage biotechnology company, announces the filing of an extended FDA Investigational New Drug (IND) application to study the treatment of COVID-19 related inflammatory disease using Kimera’s first-in-class XoGlo® isolated placental mesenchymal stem cell-based exosomes.

Read more